ClinicalTrials.Veeva

Menu

CARTO 3 Human Patch Study

Biosense Webster logo

Biosense Webster

Status

Withdrawn

Conditions

Healthy

Treatments

Device: ACL Patch

Study type

Observational

Funder types

Industry

Identifiers

NCT00767390
Rep2952

Details and patient eligibility

About

The Purpose of this clinical investigation is to observe the changes in relative conductivity between the six ACL patches over time. In addition, the clinical investigation will evaluate the impact of prolonged placement of the ACL patches on subjects' skin on the chest and back. During the study the adhesiveness properties of the patches will be evaluated.

Sex

All

Ages

20 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Signed Subject Informed Consent Form
  • Healthy subject
  • Age Range: 20 - 50 years
  • BMI - half o the subjects 18-25 and half >25
  • Chest cage normal anatomy and dimensions
  • No history of skin contact patch allergy, of any kind

Exclusion criteria

  • Chest cage bony deformity
  • Known skin allergies to patches, or dermatological conditions requiring therapy
  • Presence of any active skin lesion on chest or back
  • Any condition that preclude subject from lying down for six hours with minimal movement
  • Pregnancy
  • Subjects with devices, such as pace makers, IC, loop recorder

Trial design

0 participants in 1 patient group

ACL Patch
Treatment:
Device: ACL Patch

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems